Clinical Trials · NCT01815138
Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- UConn Health
- Enrollment
- 89
- Start date
- Mar 2013
- Locations
- 1 site, United States
- Primary endpoint
- Ongoing Pregnancy